Phoenix share price may be flat, but its 8.3% yield could build a strong second income

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.

Despite limited share price progress in recent years, the Phoenix (LSE: PHNX) share price continues to reward patient investors through reliable dividends. With one of the highest yields in the FTSE 100 and a solid record of payout growth, the insurer still offers appeal for those focused on building steady passive income over time.

Steady accumulator

Over the last 10 years, the insurer’s dividends per share (DPS) have grown at a compound annual growth rate of around 3.2%.

For income chasers, I believe it’s important to use historical DPS growth as a guide when modelling future returns. A 3% annual increase in the cash cost of the dividend looks a realistic assumption.

The following chart shows how a £5,000 investment could grow over the next 15 years, assuming a flat share price.

Chart generated by author

The key takeaway is that compounding is an investor’s best friend. Reinvesting dividends to buy additional income-generating units creates an exponentially growing curve, far more powerful than the linear growth achieved by withdrawing cash each year.

Dividend sustainability

It is all well and good building a future income model, but I also need confidence that profits will keep growing to sustain those payouts.

Phoenix operates with a clear capital allocation framework, with dividend increases linked to three factors.

First, and most importantly, is operating capital generation (OCG). At H1 2025, OCG stood at £705m, of which only £274m was paid out in dividends. That leaves the business with plenty of headroom to reinvest for growth.

Second is the solvency coverage ratio, currently 175%, placing it in the upper half of its operating range. Such a high figure reflects a robust balance sheet capable of absorbing financial shocks.

Finally, distributable reserves are extremely healthy at £5.5bn, up 20% year on year.

Accounting quirk

The insurer’s H1 results highlighted that shareholders’ equity, based on statutory accounting principles (IFRS), fell 37% to £768m. However, on an adjusted basis it came in at £3.5bn, a substantial discrepancy.

The company explained the decline as an “accounting mismatch” between IFRS and its preferred Solvency II framework. Under IFRS, long-term investment contracts such as annuities are valued using fixed economic assumptions, while Solvency II re-values them each period to reflect market conditions. Consequently, this can lead to vastly different valuation metrics for individual financial assets.

It may just be an accounting quirk, but if IFRS shareholders’ equity fails to recover over time, investors may begin to question the long-term sustainability of the dividend.

Bottom line

For now, Phoenix remains one of the FTSE 100’s most reliable income plays. The share price may be static, but the dividend is well-covered, supported by strong capital generation and solid reserves.

For patient investors seeking predictable cash flow and gradual compounding, the stock is worthy of consideration, even if capital growth remains elusive.

The post Phoenix share price may be flat, but its 8.3% yield could build a strong second income appeared first on The Motley Fool UK.

Should you invest £1,000 in Phoenix Group Holdings plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Phoenix Group Holdings plc made the list?

More reading

Andrew Mackie has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.